These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 30642354)

  • 21. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
    Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is clinical target volume necessary for locally advanced non-small cell lung cancer treated with 4D-CT intensity-modulated radiation therapy.
    Ding W; Xu T; Xiang H; Liang J; Liang W; Xiang N; Zhao J; Li G; Song Z
    BMC Cancer; 2024 Sep; 24(1):1198. PubMed ID: 39334061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
    Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
    Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis.
    Uchida Y; Tsugawa T; Tanaka-Mizuno S; Noma K; Aoki K; Shigemori W; Nakagawa H; Kinose D; Yamaguchi M; Osawa M; Ogawa E; Nakano Y
    Radiat Oncol; 2017 Oct; 12(1):160. PubMed ID: 28969651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ipsilateral lung dose as a correlative measure for radiation pneumonitis in patients treated with definitive concurrent radiochemotherapy.
    Kirakli EK; Erdem S; Susam S; Erim E
    J Cancer Res Ther; 2023; 19(5):1153-1159. PubMed ID: 37787278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
    Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J
    Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Shi A; Zhu G; Wu H; Yu R; Li F; Xu B
    Radiat Oncol; 2010 May; 5():35. PubMed ID: 20462424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric Factors and Radiomics Features Within Different Regions of Interest in Planning CT Images for Improving the Prediction of Radiation Pneumonitis.
    Jiang W; Song Y; Sun Z; Qiu J; Shi L
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1161-1170. PubMed ID: 33548340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
    Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.
    Tucker SL; Xu T; Paganetti H; Deist T; Verma V; Choi N; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):403-410. PubMed ID: 30291994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in lung injury after IMRT or proton therapy assessed by
    Shusharina N; Liao Z; Mohan R; Liu A; Niemierko A; Choi N; Bortfeld T
    Radiother Oncol; 2018 Jul; 128(1):147-153. PubMed ID: 29352608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the radiation pneumonia development risk in lung cancer cases.
    Yilmaz S; Adas YG; Hicsonmez A; Andrieu MN; Akyurek S; Gokce SC
    Asian Pac J Cancer Prev; 2014; 15(17):7371-5. PubMed ID: 25227844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT.
    Kumar G; Rawat S; Puri A; Sharma MK; Chadha P; Babu AG; Yadav G
    Jpn J Radiol; 2012 Jan; 30(1):18-24. PubMed ID: 22160648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.
    Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E
    Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.